Metraipolis › archive › dc_5f362fb7de6f
Unleashing innovative cross-organ fibrosis therapies by harnessing the omics revolution — Europe PMC PMID:42417159
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42417159
- DOI
- 10.1172/jci.insight.200155
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T10:26:58.310Z
- SHA-256 of the archived text
df6768d20c912d8681670a4e2b6dfcafc60acff5b5f32e63fc1dffa710908e11- Stable URL of this page
https://metraipolis.com/documento/dc_5f362fb7de6f
How to cite
Unleashing innovative cross-organ fibrosis therapies by harnessing the omics revolution — Europe PMC PMID:42417159 — Europe PMC (en), https://europepmc.org/article/MED/42417159 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5f362fb7de6f (Metraipolis archive dc_5f362fb7de6f, sha256 df6768d20c912d8681670a4e2b6dfcafc60acff5b5f32e63fc1dffa710908e11)
BibTeX
@misc{dc5f362fb7de6f,
title = {Unleashing innovative cross-organ fibrosis therapies by harnessing the omics revolution — Europe PMC PMID:42417159},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42417159},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5f362fb7de6f; sha256 df6768d20c912d8681670a4e2b6dfcafc60acff5b5f32e63fc1dffa710908e11},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42417159. Agents can read the archived copy with the MCP tool read_document.